Table 4.
The AUC for Detecting any VIP-Targeted Eye Conditions by Age
| Screener | AUC (95% CI) |
|||
|---|---|---|---|---|
| 3-Year-Olds | 4- and 5-Year-Olds | P (AUC Comparison between Age Groups) | ||
| VIP Phase I, Year 1 (n = 1142) | (n = 215) | (n = 927) | ||
| NCR | LEP | 0.82 (0.76–0.89) | 0.84 (0.81–0.87) | 0.67 |
| Retinomax | LEP | 0.88 (0.81–0.94) | 0.82 (0.79–0.86) | 0.16 |
| P for AUC comparison between instruments | 0.24 | 0.33 | ||
| VIP Phase I, Year 2 (n = 1446) | (n = 293) | (n = 1153) | ||
| Retinomax | LEP | 0.87 (0.81–0.92) | 0.86 (0.83–0.88) | 0.81 |
| SureSight | LEP | 0.84 (0.78–0.90) | 0.87 (0.84–0.89) | 0.48 |
| P for AUC comparison between instruments | 0.41 | 0.67 | ||
| VIP Phase II (n = 1452) | (n = 377) | (n = 1075) | ||
| Retinomax | Nurse | 0.83 (0.79–0.88) | 0.90 (0.87–0.92) | 0.02 |
| LAY | 0.85 (0.80–0.89) | 0.90 (0.87–0.92) | 0.03 | |
| P for AUC comparison between screeners | 0.62 | 0.93 | ||
| SureSight | Nurse | 0.86 (0.81–0.90) | 0.88 (0.86–0.91) | 0.29 |
| LAY | 0.85 (0.80–0.89) | 0.88 (0.85–0.90) | 0.21 | |
| P for AUC comparison between screeners | 0.67 | 0.73 | ||
| P for AUC comparison between instruments | 0.45 | 0.29 | ||